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A b s t r a c t
Background and aim: The aim of this study was to examine contemporary results of accessory pathway (AP) ablation in 
a sizeable number of patients, focusing on periprocedural complications and the learning curve. 
Methods: We performed a retrospective cohort study of consecutive AP ablation procedures at three centres by the same 
operator. In total 629 electrophysiological studies and 610 AP ablation procedures were performed in 570 patients (age: 
33 ± 18.9 years).  
Results: There was one (0.16%) serious and there were 14 (2.3%) minor periprocedural complications. Five hundred and 
ninety APs were successfully ablated: single/multiple procedure success was 93.4%/96.7%, while the average fluoroscopy time 
was 13.5 min. There was significantly higher success and less fluoroscopy use with increased experience, while periprocedural 
complications seemed evenly distributed over the years. The learning was most pronounced for the first 120 cases. However, 
the learning curve fully flattened only after approximately 400 ablations.  
Conclusions: This study suggests that in the modern era AP ablation is safer than it was in the first two decades after the 
introduction of catheter ablation of APs. Perhaps, in experienced centres there should be a lower threshold for referring as-
ymptomatic/mildly symptomatic patients with pre-excitation for electrophysiological study.
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INTRODUCTION
Soon after the first catheter ablations of accessory pathways 
(AP) were reported in the 1980s catheter-based ablation 
became a standard therapeutic approach in Wolff-Parkin-
son-White (WPW) syndrome [1, 2].
Indications for this procedure are based not only on the 
tachyarrhythmia-related symptoms and the risk of serious 
consequences of untreated AP, but they also take into account 
the risks of the ablation procedure [3, 4]. The issue of serious 
complications of AP ablation is probably the most common 
reason for the failure to perform this usually curative proce-
dure in asymptomatic or mildly symptomatic patients with 
overt pre-excitation. The efficacy and safety of AP ablation 
have been reported by several studies, albeit mainly in the 
previous century, soon after the introduction of this method 
[5–10]. Continuous fine-tuning of the ablation technique, 
better understanding of the electrophysiology and anatomy 
of the heart, and also technological advances (cryoablation, 
three-dimensional [3D] mapping systems) in the last decades 
could have influenced both the safety and success rates of 
this procedure. We believe that there is a scarcity of data 
concerning the outcomes of XXI-century AP ablation when 
performed by experienced operators. 
The primary aim of this study was to examine contem-
porary periprocedural complications and the learning curve 
of AP ablation in a sizeable number of patients. 
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METHODS 
We performed a retrospective cohort study of consecutive 
AP ablation procedures at three centres by the same operator 
(M.J.), from 2002 to mid-2016. For this, all ablation procedure 
descriptions, digital EP system records, hospital discharge 
notes, and pre- and post-procedural 12-lead electrocardio-
grams (ECG) of all patients scheduled for ablation were care-
fully reviewed. Pertinent clinical data such as age, gender, 
the presence of symptoms prior to ablation, occurrence of 
cardiac arrest/malignant atrial fibrillation (defined as need for 
emergency cardioversion or syncope/presyncope symptoms 
and ECG with shortest RR intervals < 250 ms), were col-
lected. The procedure-related following data were gathered: 
AP localisation (based on the stored fluoroscopic images of 
the catheter at the successful ablation site in anteroposterior 
and left anterior oblique views), ablation success/failure, and 
periprocedural complications. Successful procedure was 
defined as 1) complete elimination of AP conduction after 
a 30-min. waiting period; 2) lack inducibility of any atrioven-
tricular (AV) re-entrant tachycardia, and 3) lack of recurrence 
of overt pre-excitation or tachycardia during the pre-discharge 
period of 24–48 h. Serious periprocedural complications were 
defined as: death, stroke, systemic embolism, second- and 
third-degree AV block or pacemaker implantation, tampon-
ade, and any other life threatening event or the need for 
surgical intervention. Minor complications included bundle 
branch blocks, asymptomatic first-degree AV block, pericar-
dial effusion treated conservatively, groin problems treated 
conservatively, and uncomplicated pneumothorax. Obtained 
data were later analysed by an independent biostatistician.
All procedures were performed with the same simpli-
fied three-catheter approach: 1) His bundle/right ventricular 
catheter, 2) coronary sinus (for left-sided APs) or right atrial 
(for right-sided and septal APs) catheter, and 3) radiofrequency 
ablation catheter (irrigated catheter for retrograde aortic ac-
cess or coronary sinus/cardiac vein ablation and non-irrigated 
catheter for other APs/access routes). The following abla-
tion settings were used: 35 W/57oC for non-irrigated and 
30 W/43oC for irrigated catheters. For ablation in coronary 
sinus and cardiac veins, lower power (20–25 W) and shorter 
time (30 s instead of 1 min) was used. Femoral vein, femoral 
artery and left subclavian vein access were used as considered 
appropriate. The only change in the ablation strategy during 
the 14-year study period was: 1) switch to routine placement 
of the coronary sinus catheter via femoral access from a previ-
ously used subclavian access after the first 210 cases (because 
of two pneumothoraces) and the introduction of a transseptal 
puncture for selected left-sided pathways (however, only when 
transaortic approach failed or was prolonged/difficult) after the 
first 284 cases. AP ablation procedures were performed by 
an electrophysiology specialist with considerable experience 
in general interventional electrocardiology (over 4400 proce-
dures, including approximately 2800 ablations/electrophysi-
ological studies performed during the study period). For all 
electrophysiological studies, a BARD EP system and a mobile 
C-arm were used. 
Statistical analysis
Categorical variables were expressed as counts and percent-
ages, and continuous variables as means and standard devia-
tions. The association between binary and the continuous 
variable was estimated using splines in the logistic regression 
model, and for two continuous variables the spline fit was 
obtained using the least squares method. A p-value less than 
0.05 was considered statistically significant. All statistical 
analyses were performed using R 3.2.
RESULTS
We identified 570 consecutive patients scheduled for elec-
trophysiological study/AP ablation, on whom 629 electro-
physiological studies and 610 AP ablation procedures were 
performed; 21 patients had more than one AP and there 
were 40 re-do procedures including 16 long-term recur-
rences. One patient died 14 days before scheduled ablation 
(due to ventricular fibrillation) and was therefore excluded 
from analysis of procedure success and ablation complications, 
but he was included in the list of the serious pre-ablation 
AP-related events. Basic clinical and demographical data, 
as well ablation strategy/technique, AP localisations, and AP 
types/variants, some of which were earlier described [10–13], 
are presented in Table 1.
Overall, 590 APs were successfully ablated, which consti-
tuted 96.7% of all targeted APs; single procedure success was 
93.4%, and average fluoroscopy time was 13.5 min (142 mGy) 
(Table 1). Focal cryoablation, stabilising long sheets, and/or 
3D mapping systems were used in 16% of cases. The learn-
ing curve with regard to single procedure success, multiple 
procedure success, fluoroscopy time reduction, and peripro-
cedural complications are presented in Figure 1. Briefly, there 
was significantly higher success and less fluoroscopy use with 
increase in experience (p = 0.049 and p < 0.0001, respec-
tively), while periprocedural complications seemed evenly 
distributed over the years (p = 0.92). The learning was most 
pronounced in the first 120–140 cases. However, the learning 
curve fully flattened only after approximately 400 ablations 
(Fig. 1). The learning curve with regard to the most frequent 
AP localisation (and considered also as indicative of easier 
ablation) — i.e. left free wall APs vs. other APs, is presented in 
Figure 2. With the left free wall APs there was initially a very 
high success rate, and therefore the learning curve in this 
subgroup was flat. This was in contrast to the learning curves 
in the subgroup consisting of the remaining APs: for single 
procedure a plateau was reached after 150 cases (p = 0.036), 
although for multiple procedure the success rate was rising 
with growing experience during the included 300 cases 
(p = 0.028). Furthermore, AP localisation significantly influ-
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enced first procedure success rate, with 97% success rate in 
left lateral/anterolateral pathways vs. 88–90% success rate 
in right free wall and epicardial/septal pathways. However, 
multiple procedure success rate was lower only for right 
free wall APs (Fig. 2). The success rate with regard to the 
precise anatomical AP localisation, presented in Table 2, 
indicates significantly lower multiple procedure success rate 
in para-Hisian and right posterolateral APs. 
Table 3 lists periprocedural complications and AP-related 
adverse events observed before ablation. Briefly, there was 
one (0.16%) serious periprocedural complication (a tam-
ponade without further sequelae) and 14 (2.3%) minor 
complications; serious pre-ablation AP-related events were 
observed in 36 (6.3%) patients, including 12 sudden cardiac 
arrests (two resulting in serious permanent brain damage and 
one in death) and 16 pre-cardiac arrest situations (malignant 
atrial fibrillation). 
DISCUSSION
Periprocedural complications
The major finding of this study is that in contrast to the early 
studies on WPW ablation [5, 14, 15], there were almost no 
serious complications of AP ablation (major complication rate 
of 0.2% — reflecting a single case of tamponade that was 
managed with straightforward pericardiocentesis during the 
procedure). It is commonly held that the major complication 
rate in AP ablation is 2–3%, and that this number should be 
weighed against the benefits of ablation [3, 5, 16]. However, 
this view is mostly based on the results of early studies. In 
these studies, for example, in the Multicentre European Radi-
ofrequency Survey (MERFS), the incidence of complications 
in relation to the ablation of AP was 4.4%, and this included 
three deaths [15]. In another study, 500 patients who under-
went catheter ablation of an AP complications included 1% of 
complete AV blocks, 0.2% of deaths, and 0.2% of strokes [5]. 
However, the recent study by Pappone et al. [17] corroborates 
our finding of very low rate of serious complications and 
similar low rate of minor complications during contemporary 
ablation of APs. In this very large study, there were no deaths, 
no tamponades, and only a single case of third-degree AV 
block (0.08%); minor complications rate was similar to that 
of the current study and included pneumothorax in 0.2%, 
femoral haematomas in 1.9%, fistulas in 0.16%, right bundle 
branch block in 0.9%; left bundle-branch block in 0.3%, and 
asymptomatic pericardial effusion in 0.2%. Of note, techno-
logical solutions rarely used in the 1990s (focal cryoablation, 
stabilising long sheets, or 3D mapping systems) were used in 
the current study during 16% of ablations, perhaps reducing 
risk in selected, difficult cases.
Success rate and learning curve for AP ablation
The efficacy of AP ablation of approximately 97% seen in the 
current study is similar to that seen in high-volume leading 
centres, as reported by Nakagawa and Jackman [18] (97.6%) 
and Pappone et al. [17] (98.5%) and slightly higher than in 
most early studies (86–95%) [7, 17, 19, 20]. Right free wall AP 
location was associated with a lower success rate for the first 
and multiple attempts (Fig. 3). However, the septal pathways 
success rate was lower for only the first ablation attempt (with 
the possible exception of para-Hisian pathways).
In the current study the learning curves for both success 
rate and fluoroscopy time flattened after 400 cases; this is the 
first report that shows a contemporary single operator learning 
curve in a large number of patients. Shorter procedure dura-
tion (but without data on fluoroscopy time) and higher suc-
cess rate with experience, was reported by Calkins et al. [10], 
Table 1. Clinical and electrophysiological characteristics
Number of patients/APs/ablation procedures [n] 570/630/610
Age [years] 33 ± 18.9 
Males 56.1%
Asymptomatic patients 16.5%
AP localisation:
Left free wall 50.6%
Posteroseptal (right and left) 19.6%
Right free wall 10.2%
Midseptal (right and left) 7.8%
Right anteroseptal 5.3%
Para-Hisian 3.1%
Epicardial 1.8%
Fasciculoventricular (true Mahaim) 1.3%
In aortomitral continuity 0.16%
Atrio-Hisian (James) 0.16%
AP functional types:
Overt 67.8%
Concealed 29.7%
Concealed slow/decremental (Coumel) 1.1%
Atriofascicular (pseudo-Mahaim) 1.4%
Single/multiple procedure success rate 93.4%/96.7%
Mean fluoroscopy time [min] 13.5 ± 12.1
Use of: 
Cryoablation 4.7%
Stabilising sheets 6.2%
Three-dimensional system 5.1%
Ablation access:
Retrograde aortic 50.0%
Transseptal puncture 1.9%
Patent foramen ovale 2.9%
Right atrium: via superior/inferior vena cava 42.5%
Coronary sinus 2.5%
AP — accessory pathways
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Figure 1. Logistic regression spline fit (solid blue line), overall mean (dashed line); A. Increase in probability of success during the 
first attempt at accessory pathways (AP) ablation is most obvious for the first 140 cases and reaches a plateau after 400 cases;  
B. Increase in multiple attempts success probability is continuous, but becomes minimal after 400 cases; C. Decrease in fluoroscopy  
use is most dramatic during the first 120 cases and reaches a plateau after 400 cases; D. There is no statistical significance for 
distribution of complications of AP ablation during the 629 procedures spanning a 14-year period
Figure 2. Logistic regression spline fit (solid blue line), overall mean (dashed line); A. Single procedure success rate curve for left 
free wall accessory pathways (AP) ablation is flat — reflecting the initially very high probability of success; B. Multiple procedure 
success rate curve for left free wall APs ablation does not change with increase in experience; C. Single procedure success rate 
curve for non left free wall APs ablation reaches a plateau after the first 150 cases; D. Multiple procedure success rate curve for 
non left free wall APs ablation is rising with experience during the included 300 cases
A B
C D
A B
C D
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although these data came from a group of several opera-
tors. Danford et al. [14] reported the learning curve for AP 
ablation in children/adolescents. However, the data were 
also from the early 1990s and fluoroscopy times were several 
times longer (72–36 min) than in the current study (13.5 min).
Data concerning learning curve and achievable low com-
plication rates when procedures are performed by an expe-
rienced operator/centre might be more important nowadays 
because AP ablation is becoming a less common procedure, 
with most electrophysiologists/centres busy with atrial fibril-
lation and ventricular tachycardia ablation.
Limitations of the study
Due to the retrospective nature of the study, minor complica-
tions might have been underreported and therefore underes-
timated, especially local access-related vascular complications 
like haematomas, arteriovenous fistulas, and pseudoaneurysms.
Acute and short-term success investigated in the current 
study does not equal long-term success, due to a known small 
recurrence rate in AP conduction after initially successful 
ablation. We did not aim at analysing the long-term success 
rate due to lack of rigorous long-term follow-up in our cohort. 
Nevertheless, long-term success can be approximated as all 
patients were strongly recommended to have an ECG after 
two to three months and to visit our outpatient department 
in the case of overt pre-excitation in the ECG or symptom 
recurrence. Probably the 16 cases reported by us represent 
the majority of patients with long-term recurrences. All APs 
with long-term recurrence of conduction were re-ablated 
successfully and without complications.
CONCLUSIONS
The current study suggests that in the modern era AP abla-
tion can be safer than it was in the first two decades after the 
Figure 3. Single procedure ablation success rate for right free 
wall accessory pathways (AP) and septal/epicardial APs was sig-
nificantly lower than that of left free wall pathways (p < 0.01). 
Multiple attempts success rate was lower only for right free 
wall APs (p < 0.01)
Table 2. Impact of accessory pathway (AP) localisation on 
ablation success
AP localisation First attempt  
success  
rate
Multiple  
attempts  
success rate
Right anterior 90.0% 100.0%
Right anterolateral 88.9% 88.9%
Right lateral  94.1% 100.0%
Right posterolateral 76.5%* 76.5%*
Right posterior 93.8% 93.8%
Right posteroseptal 92.6%* 94.7%
Right midseptal 100.0% 100.0%
Right anteroseptal 84.4%* 93.8%
Para-Hisian 83.3%* 88.9%**
Epicardial 66.7%* 91.7%
Left midseptal 71.4%* 100.0%
Left posteroseptal 92.6% 100.0%
Left posterior 93.2%* 98.3%
Left posterolateral 95.7% 100.0%
Left lateral/anterolateral 98.5% 98.5%
*p < 0.05 vs. left lateral/anterolateral; **p = 0.054 vs. left lateral/ 
/anterolateral
Table 3. Ablation complications and serious events related to 
untreated accessory pathway (AP)
Major periprocedural complications
Death 0 (0%) 
Stroke 0 (0%)
II/III degree AV block or pacemaker implantation 0 (0%)
Tamponade 1 (0.16%)
Need for surgical intervention 0 (0%)
Minor periprocedural complications
I degree AV block 1 (0.16%)
RBBB 3 (0.48%)
LBBB 1 (0.16%)
Pericardial fluid 1 (0.16%)
Pneumothorax 2 (0.32%)
Groin haematoma  3 (0.48%)
Arteriovenous fistula/femoral artery aneurysm 1 (0.16%)
Deep vein thrombosis 2 (0.32%)
Aortic valve insufficiency (I degree) 1 (0.16%)
Serious events related to untreated APs
Sudden cardiac arrest (ventricular fibrillation)# 12 (3.1%)*
Malignant AF/near cardiac arrest 16 (4.1%)*
Other (syncope, heart failure, etc.) 9 (1.6%)
*Calculated for patients with overt AP (n = 386); #resulting in perma-
nent serious brain damage in two and death in one (0.8%); AF — atrial 
fibrillation; AV — atrioventricular block; LBBB — left bundle branch 
block; RBBB — right bundle branch block
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introduction of catheter ablation of APs. Moreover, this larg-
est single-operator data on AP ablation outcomes indicates 
that experience builds up over several hundred ablation 
cases. These results, viewed in the perspective of the rare yet 
potentially devastating consequences of untreated AP, suggest 
that in experienced centres there should be less reluctance 
to routinely perform electrophysiological study in asympto-
matic/mildly symptomatic patients with pre-excitation.
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Współczesne wyniki ablacji szlaków dodatkowych: 
powikłania i krzywa uczenia się
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3Wydział Statystyki, Uniwersytet Ekonomiczny, Kraków
S t r e s z c z e n i e
Wstęp i cel: Celem badania była ocena współczesnych wyników ablacji szlaków dodatkowych w dużej grupie chorych, 
ukierunkowana na analizę powikłań oraz krzywej uczenia się.
Metody: Wykonano retrospektywne badanie kohortowe obejmujące kolejne zabiegi ablacji szlaku dodatkowego przepro-
wadzone w trzech ośrodkach przez tego samego operatora. Przeanalizowano 629 badań elektrofizjologicznych i 610 ablacji 
przeprowadzonych u 570 pacjentów (wiek 33 ± 18,9 roku).
Wyniki: Wystąpiło jedno (0,16%) poważne powikłanie i 14 (2.3%) lżejszych powikłań. 590 szlaków poddano skutecznej 
ablacji: odsetek udanych zabiegów przy jednej sesji i kilku sesjach ablacyjnych wyniósł odpowiednio 93,4% i 96,7%; średni 
czas zastosowania promieniowania rentgenowskiego (RTG) wyniósł 13,5 min. Wraz z doświadczeniem w sposób istotny 
wzrósł odsetek udanych zabiegów, a obniżył się czas promieniowania RTG, natomiast powikłania były równomiernie rozło-
żone w czasie. Efekt uczenia był najwyraźniejszy w ciągu pierwszych 120 przypadków, jednak pełne wypłaszczenie krzywej 
uczenia się nastąpiło dopiero po 400 ablacjach.
Wnioski: Wyniki badania sugerują, że w XXI wieku ablacja szlaków dodatkowych jest bezpieczniejsza niż w pierwszych dwóch 
dekadach od wprowadzenia przezskórnych ablacji szlaków dodatkowych. Wydaje się, że w doświadczonych ośrodkach za-
sadny jest niższy próg decyzyjny przy kierowaniu bezobjawowych chorych z preekscytacją na badanie elektrofizjologiczne.
Słowa kluczowe: szlak dodatkowy, preekscytacja, ablacja, powikłania, krzywa uczenia się
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